FindTrial
Sign In

Establishment and validation of TCM syndrome diagnosis model for patients with systemic lupus erythematosus based on eXtreme Gradient Boosting

Establishment and validation of TCM syndrome diagnosis model for patients with systemic lupus erythematosus based on eXtreme Gradient Boosting

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065030
Enrollment
Unknown
Registered
2022-10-26
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

Disease group:NO use

Sponsors

Hainan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria of Western medicine for systemic lupus erythematosus; All patients who voluntarily participated in the study (signed informed consent) were included; People aged 30-70.

Exclusion criteria

Exclusion criteria: Combined with other connective tissue diseases; Other serious diseases such as cardiovascular, cerebrovascular and hematopoietic system. Pregnant or lactating women; Combined with neurological and mental disorders; Or unable to cooperate with this test.

Design outcomes

Primary

MeasureTime frame
Clinical information;—

Countries

China

Contacts

Public ContactGong Aimin

Hainan Medical College

422789075@qq.com+86 18976678099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026